Oyster Point Pharma
Patents, Design & Utilities

Last updated:

List of all Oyster Point Pharma patents 11 in total

Status Patent
Application
Utility: DRY EYE TREATMENTS External link
Filling date: 26 Sep 2025 Issue date: 28 Jul 2022
Application
Utility: NESTING STRUCTURES FOR STORAGE, TRANSPORT, AND ASSEMBLY OF DRUG DISPENSERS AND CONTAINERS External link
Filling date: 26 Sep 2025 Issue date: 21 Jul 2022
Application
Utility: COMBINATIONS OF POSITIVE ALLOSTERIC MODULATORS AND NICOTINIC ACETYLCHOLINE RECEPTOR AGONISTS FOR TREATING OCULAR CONDITIONS External link
Filling date: 26 Sep 2025 Issue date: 9 Dec 2021
Application
Utility: SYNTHESIS AND NOVEL SALT FORMS OF (R)-5-((E)-2-PYRROLIDIN-3-YLVINYL)PYRIMIDINE External link
Filling date: 26 Sep 2025 Issue date: 2 Dec 2021
Grant
Utility: Synthesis and novel salt forms of (R)-5-((E)-2-pyrrolidin-3-ylvinyl)pyrimidine External link
Filling date: 26 Sep 2025 Issue date: 16 Feb 2021
Application
Utility: METHODS OF TREATING OCULAR CONDITIONS External link
Filling date: 26 Sep 2025 Issue date: 5 Nov 2020
Application
Utility: DRY EYE TREATMENTS External link
Filling date: 26 Sep 2025 Issue date: 6 Aug 2020
Grant
Utility: Methods of treating ocular conditions External link
Filling date: 26 Sep 2025 Issue date: 14 Jul 2020
Application
Utility: SYNTHESIS AND NOVEL SALT FORMS OF (R)-5-((E)-2-PYRROLIDIN-3-YLVINYL)PYRIMIDINE External link
Filling date: 26 Sep 2025 Issue date: 2 Jul 2020
Grant
Utility: Dry eye treatments External link
Filling date: 26 Sep 2025 Issue date: 29 Oct 2019
Grant
Utility: Salt forms of (R)-5-((E)-2-pyrrolidin-3-ylvinyl)pyrimidine External link
Filling date: 26 Sep 2025 Issue date: 24 Sep 2019

Showing 1 to 11 of 11 patents.